Psychopharmacologic treatment of aggressive preschoolers: a chart review

Jud A Staller1

  • 1Division of Child and Adolescent Psychiatry, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

Insights

Medication is increasingly used for severe aggression in young children, with atypical antipsychotics, stimulants, and alpha agonists showing moderate to marked improvement in most cases. Further research is needed.

Area of Science:

  • Child and Adolescent Psychiatry
  • Pediatric Psychopharmacology

Background:

  • Severe aggression in very young children is a growing concern in child psychiatry.
  • Medication is increasingly considered for treating severe aggression in preschoolers, despite limited research.
  • Diagnostic uncertainties are common in this age group.

Purpose of the Study:

  • To review patient characteristics, diagnoses, and treatment responses in aggressive preschoolers.
  • To evaluate the effectiveness of various medications for severe aggression in young children.

Main Methods:

  • Chart review of aggressive preschoolers treated at a university child psychiatry outpatient clinic (2001-2004).
  • Analysis of diagnoses, prescribed medications, and treatment response ratings.

Main Results:

  • Common diagnoses included Attention Deficit Hyperactivity Disorder (ADHD), Disruptive Behavior Disorder, and Posttraumatic Stress Disorder (PTSD).
  • A majority of children received medication, most frequently atypical antipsychotics, followed by stimulants and alpha agonists.
  • Moderate to marked improvement was observed in most preschoolers treated with medication or combination therapy.

Conclusions:

  • Medication, particularly atypical antipsychotics, stimulants, and alpha agonists, appears effective for severe aggression in preschoolers.
  • Findings highlight the need for controlled trials to establish evidence-based medication guidelines for this population.

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...